Comparing cutaneous research funded by the US National Institutes of Health (NIH) with the US skin disease burden

Erika L. Hagstrom, Shivani Patel, Chante Karimkhani, Lindsay N. Boyers, Hywel C. Williams, Roderick J. Hay, Martin A. Weinstock, April W. Armstrong, Cory A. Dunnick, David J. Margolis, Robert P. Dellavalle

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Background Disease burden should be an important component for guiding research funding. Objective We sought to examine the relationship between dermatologic research funded from 2012 to 2013 by the National Institutes of Health (NIH) and US skin disease burden as measured by disability-adjusted life years in the Global Burden of Disease 2010 study. Methods A cross-sectional analysis was independently performed by 2 researchers who matched projects from the 2012 to 2013 NIH Research Portfolio Online Reporting Tools with 15 skin conditions and their respective disability-adjusted life years from Global Burden of Disease 2010. Results The NIH funded 1108 projects spanning the 15 skin conditions. Melanoma received almost half of the total skin condition budget (49.5%). Melanoma, nonmelanoma skin cancer, and leprosy were funded above what would be suggested by their disease burden, whereas dermatitis, acne vulgaris, pruritus, urticaria, decubitus ulcer, fungal skin diseases, alopecia areata, cellulitis, and scabies appeared underfunded. Bacterial skin diseases, viral skin diseases, and psoriasis were well matched with disease burden. Limitations Disease burden is one of many factors that may be used to guide priority-setting decisions. Conclusion Skin disease burden measured by disability-adjusted life year metrics partially correlates with NIH funding prioritization. Comparing US disease burden with NIH funding suggests possible underfunded and overfunded skin diseases.

Original languageEnglish (US)
Pages (from-to)383-391.e1
JournalJournal of the American Academy of Dermatology
Volume73
Issue number3
DOIs
StatePublished - Sep 1 2015
Externally publishedYes

Fingerprint

National Institutes of Health (U.S.)
Skin Diseases
Quality-Adjusted Life Years
Skin
Research
Bacterial Skin Diseases
Viral Skin Diseases
Melanoma
Dermatomycoses
Alopecia Areata
Scabies
Cellulitis
Pressure Ulcer
Urticaria
Acne Vulgaris
Skin Neoplasms
Dermatitis
Budgets
Leprosy
Pruritus

Keywords

  • dermatitis
  • disability-adjusted life years
  • disease burden
  • leprosy
  • melanoma
  • National Institutes of Health
  • priority setting
  • skin conditions

ASJC Scopus subject areas

  • Dermatology

Cite this

Hagstrom, E. L., Patel, S., Karimkhani, C., Boyers, L. N., Williams, H. C., Hay, R. J., ... Dellavalle, R. P. (2015). Comparing cutaneous research funded by the US National Institutes of Health (NIH) with the US skin disease burden. Journal of the American Academy of Dermatology, 73(3), 383-391.e1. https://doi.org/10.1016/j.jaad.2015.04.039

Comparing cutaneous research funded by the US National Institutes of Health (NIH) with the US skin disease burden. / Hagstrom, Erika L.; Patel, Shivani; Karimkhani, Chante; Boyers, Lindsay N.; Williams, Hywel C.; Hay, Roderick J.; Weinstock, Martin A.; Armstrong, April W.; Dunnick, Cory A.; Margolis, David J.; Dellavalle, Robert P.

In: Journal of the American Academy of Dermatology, Vol. 73, No. 3, 01.09.2015, p. 383-391.e1.

Research output: Contribution to journalArticle

Hagstrom, EL, Patel, S, Karimkhani, C, Boyers, LN, Williams, HC, Hay, RJ, Weinstock, MA, Armstrong, AW, Dunnick, CA, Margolis, DJ & Dellavalle, RP 2015, 'Comparing cutaneous research funded by the US National Institutes of Health (NIH) with the US skin disease burden', Journal of the American Academy of Dermatology, vol. 73, no. 3, pp. 383-391.e1. https://doi.org/10.1016/j.jaad.2015.04.039
Hagstrom, Erika L. ; Patel, Shivani ; Karimkhani, Chante ; Boyers, Lindsay N. ; Williams, Hywel C. ; Hay, Roderick J. ; Weinstock, Martin A. ; Armstrong, April W. ; Dunnick, Cory A. ; Margolis, David J. ; Dellavalle, Robert P. / Comparing cutaneous research funded by the US National Institutes of Health (NIH) with the US skin disease burden. In: Journal of the American Academy of Dermatology. 2015 ; Vol. 73, No. 3. pp. 383-391.e1.
@article{4969cc3567c54ef6a730524ad71fae0e,
title = "Comparing cutaneous research funded by the US National Institutes of Health (NIH) with the US skin disease burden",
abstract = "Background Disease burden should be an important component for guiding research funding. Objective We sought to examine the relationship between dermatologic research funded from 2012 to 2013 by the National Institutes of Health (NIH) and US skin disease burden as measured by disability-adjusted life years in the Global Burden of Disease 2010 study. Methods A cross-sectional analysis was independently performed by 2 researchers who matched projects from the 2012 to 2013 NIH Research Portfolio Online Reporting Tools with 15 skin conditions and their respective disability-adjusted life years from Global Burden of Disease 2010. Results The NIH funded 1108 projects spanning the 15 skin conditions. Melanoma received almost half of the total skin condition budget (49.5{\%}). Melanoma, nonmelanoma skin cancer, and leprosy were funded above what would be suggested by their disease burden, whereas dermatitis, acne vulgaris, pruritus, urticaria, decubitus ulcer, fungal skin diseases, alopecia areata, cellulitis, and scabies appeared underfunded. Bacterial skin diseases, viral skin diseases, and psoriasis were well matched with disease burden. Limitations Disease burden is one of many factors that may be used to guide priority-setting decisions. Conclusion Skin disease burden measured by disability-adjusted life year metrics partially correlates with NIH funding prioritization. Comparing US disease burden with NIH funding suggests possible underfunded and overfunded skin diseases.",
keywords = "dermatitis, disability-adjusted life years, disease burden, leprosy, melanoma, National Institutes of Health, priority setting, skin conditions",
author = "Hagstrom, {Erika L.} and Shivani Patel and Chante Karimkhani and Boyers, {Lindsay N.} and Williams, {Hywel C.} and Hay, {Roderick J.} and Weinstock, {Martin A.} and Armstrong, {April W.} and Dunnick, {Cory A.} and Margolis, {David J.} and Dellavalle, {Robert P.}",
year = "2015",
month = "9",
day = "1",
doi = "10.1016/j.jaad.2015.04.039",
language = "English (US)",
volume = "73",
pages = "383--391.e1",
journal = "Journal of the American Academy of Dermatology",
issn = "0190-9622",
publisher = "Mosby Inc.",
number = "3",

}

TY - JOUR

T1 - Comparing cutaneous research funded by the US National Institutes of Health (NIH) with the US skin disease burden

AU - Hagstrom, Erika L.

AU - Patel, Shivani

AU - Karimkhani, Chante

AU - Boyers, Lindsay N.

AU - Williams, Hywel C.

AU - Hay, Roderick J.

AU - Weinstock, Martin A.

AU - Armstrong, April W.

AU - Dunnick, Cory A.

AU - Margolis, David J.

AU - Dellavalle, Robert P.

PY - 2015/9/1

Y1 - 2015/9/1

N2 - Background Disease burden should be an important component for guiding research funding. Objective We sought to examine the relationship between dermatologic research funded from 2012 to 2013 by the National Institutes of Health (NIH) and US skin disease burden as measured by disability-adjusted life years in the Global Burden of Disease 2010 study. Methods A cross-sectional analysis was independently performed by 2 researchers who matched projects from the 2012 to 2013 NIH Research Portfolio Online Reporting Tools with 15 skin conditions and their respective disability-adjusted life years from Global Burden of Disease 2010. Results The NIH funded 1108 projects spanning the 15 skin conditions. Melanoma received almost half of the total skin condition budget (49.5%). Melanoma, nonmelanoma skin cancer, and leprosy were funded above what would be suggested by their disease burden, whereas dermatitis, acne vulgaris, pruritus, urticaria, decubitus ulcer, fungal skin diseases, alopecia areata, cellulitis, and scabies appeared underfunded. Bacterial skin diseases, viral skin diseases, and psoriasis were well matched with disease burden. Limitations Disease burden is one of many factors that may be used to guide priority-setting decisions. Conclusion Skin disease burden measured by disability-adjusted life year metrics partially correlates with NIH funding prioritization. Comparing US disease burden with NIH funding suggests possible underfunded and overfunded skin diseases.

AB - Background Disease burden should be an important component for guiding research funding. Objective We sought to examine the relationship between dermatologic research funded from 2012 to 2013 by the National Institutes of Health (NIH) and US skin disease burden as measured by disability-adjusted life years in the Global Burden of Disease 2010 study. Methods A cross-sectional analysis was independently performed by 2 researchers who matched projects from the 2012 to 2013 NIH Research Portfolio Online Reporting Tools with 15 skin conditions and their respective disability-adjusted life years from Global Burden of Disease 2010. Results The NIH funded 1108 projects spanning the 15 skin conditions. Melanoma received almost half of the total skin condition budget (49.5%). Melanoma, nonmelanoma skin cancer, and leprosy were funded above what would be suggested by their disease burden, whereas dermatitis, acne vulgaris, pruritus, urticaria, decubitus ulcer, fungal skin diseases, alopecia areata, cellulitis, and scabies appeared underfunded. Bacterial skin diseases, viral skin diseases, and psoriasis were well matched with disease burden. Limitations Disease burden is one of many factors that may be used to guide priority-setting decisions. Conclusion Skin disease burden measured by disability-adjusted life year metrics partially correlates with NIH funding prioritization. Comparing US disease burden with NIH funding suggests possible underfunded and overfunded skin diseases.

KW - dermatitis

KW - disability-adjusted life years

KW - disease burden

KW - leprosy

KW - melanoma

KW - National Institutes of Health

KW - priority setting

KW - skin conditions

UR - http://www.scopus.com/inward/record.url?scp=84939468852&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84939468852&partnerID=8YFLogxK

U2 - 10.1016/j.jaad.2015.04.039

DO - 10.1016/j.jaad.2015.04.039

M3 - Article

VL - 73

SP - 383-391.e1

JO - Journal of the American Academy of Dermatology

JF - Journal of the American Academy of Dermatology

SN - 0190-9622

IS - 3

ER -